ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2121

Placentas of Lupus Pregnancies Are Characterized By Marked Inflammatory Changes Despite Good Disease Control

Wendy Marder1, Jason S. Knight2, Mariana J. Kaplan3, Emily C. Somers4, Xu Zhang4, Alexander A. O'Dell5, Vasantha Padmanabhan4 and Richard W. Lieberman4, 1Div of Rheumatology, University of Michigan, Ann Arbor, MI, 2Division of Rheumatology, University of Michigan, Ann Arbor, MI, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4University of Michigan, Ann Arbor, MI, 5Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Neutrophil Extracellular Traps, placenta, pregnancy and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Reproductive Issues in Rheumatic Disorders: Basic and Clinical Aspects

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:   Systemic lupus erythematosus (SLE) is associated with increased risk of adverse pregnancy outcomes (APO), including preeclampsia and intrauterine growth restriction.  While significant placental pathology is expected in patients with preeclampsia, less is known about how lupus disease activity during pregnancy affects the placenta.  Here, we describe a lupus population in which disease control was generally excellent during pregnancy, and in which only 30% of the pregnancies were complicated by preeclampsia.  In addition to standard pathologic review, we also specifically quantified neutrophils and neutrophil extracellular traps (NETs) given their recognized association with preeclampsia in the general population, as well as endothelial damage in SLE.

Methods:   Preeclampsia, SLE, and healthy placentas were scored for typical histologic features including inflammation, hemorrhage, and infarction.  Neutrophils were quantified with the aid of immunohistochemical staining for the granular protein myeloperoxidase.  NETs were identified by extracellular myeloperoxidase staining in the setting of decondensed nuclei.  Nonparametric analysis was used to evaluate differences in netting and intact neutrophils between groups.  Logistic regression was used to identify associations between histology and neutrophils.

Results:   Placentas from 11 preeclampsia, 4 SLE+preeclampsia, 10 SLE pregnancies (no preeclampsia), and 10 healthy/control pregnancies were evaluated.  Lupus disease activity during pregnancy was low in all but one patient.  Surprisingly, as compared to controls, significantly more NETs were found infiltrating not justpreeclampsia (p=0.0003) and SLE+preeclampsia (p=0.0345) placental intervillous spaces, but also all 10 of the SLE non-preeclampsia cases (p=0.0019).  The ratio of NETs to total neutrophils was also increased in all three groups (p=0.0015, p=0.0345, p=0.0019, respectively, as compared to controls).  The presence of NETs was further associated with striking histologic abnormalities including severe vasculitis with fibrinoid necrosis (p=0.02286), acute and chronic hemorrhage (p=0.02116), and laminar decidual necrosis (p=0.03458) in all groups.  In summary, the placentas of clinically-stable SLE pregnancies were markedly inflamed and essentially indistinguishable from preeclampsia placentas.

Conclusion:   Preeclampsia, SLE+preeclampsia, and clinically-stable SLE pregnancies were all associated with significantly higher numbers of intervillous NETs, and greater ratios of netting to total neutrophils as compared to controls.  This was true not just for preeclampsia placentas, but also for placentas of lupus patients whose disease activity was low during pregnancy (and who did not have clinical preeclampsia).  In summary, these data suggest lupus and preeclampsia pregnancies may share common pathogenesis that is elaborated in lupus despite clinically quiescent disease.  Future studies of lupus pregnancies are required to elucidate mechanisms of this abnormal placentation, as it may have implications for both APOs and long-term outcomes of children born to mothers with SLE.


Disclosure: W. Marder, None; J. S. Knight, None; M. J. Kaplan, None; E. C. Somers, None; X. Zhang, None; A. A. O'Dell, None; V. Padmanabhan, None; R. W. Lieberman, None.

To cite this abstract in AMA style:

Marder W, Knight JS, Kaplan MJ, Somers EC, Zhang X, O'Dell AA, Padmanabhan V, Lieberman RW. Placentas of Lupus Pregnancies Are Characterized By Marked Inflammatory Changes Despite Good Disease Control [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/placentas-of-lupus-pregnancies-are-characterized-by-marked-inflammatory-changes-despite-good-disease-control/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/placentas-of-lupus-pregnancies-are-characterized-by-marked-inflammatory-changes-despite-good-disease-control/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology